Hi Maya. I read your CLAUDE.md and everything in ./evidence (three files: the weekly funnel CSV, five tickets, one line of release notes). Nothing else is in the folder.

**Gate: passed at 95, so I'm going ahead.** Here is what I understand:

- Your ask: a one-page brief for Dana on whether to roll back the 3 Oct pricing page, based on the trial-to-paid drop.
- Who you are: Checkout PM, reporting to Dana Ortiz (VP Product). You know the funnel, not the stats, so I'll show the rows and keep it plain. Dana reads the brief.
- Goal: the draft by Fri 9 Oct, so Dana can decide at Monday's product review.
- My role: I read, analyze and draft, only in the output folder. I check with you before anything is emailed, posted, committed or pushed. I won't name a cause the data doesn't support.

Assumption: one page of plain prose plus a small table. Say if you want something else. Saved: `charter.md`.

**Phase 1 (onboard) and phase 2 (evidence map) are done**, in `working-context.md` and `evidence-map.md`. I'm stopping here because of what phase 2 found.

**What I can say so far (from the files, no cause named):**
- Conversion was steady at 0.30 to 0.31 for four weeks, then 0.22 in the week starting 5 Oct. Page views and trial starts look flat.
- Annual and monthly are split in the file. I haven't analyzed the split yet, but I can see the two cuts do not look the same size, and the tickets mostly mention annual. That is for the next phase.
- The tickets (5, all from 6 to 8 Oct) mention a different price at checkout, the annual discount gone, repeated plan selection, and unclear Studio vs Team. They hint at things to check, not proof.

**The gaps that matter, in order:**
1. There is only one post-change week, and today is 8 Oct, so it is probably not a full week. If your trials last more than a few days, trials that started 5 Oct may not have finished converting yet. That could overstate the drop, or hide how bad it is.
2. There is no control group, and I don't know whether anything else changed that week.
3. Two tickets say the checkout charged or showed a different price. That would be a bug, not a design preference, and it changes the rollback question. Nobody has checked it.

**Questions, with my guess so a "yes" is enough:**
1. How is trial_to_paid calculated, and how long is the trial? (My guess: the share of that week's trial starts that become paid, with a 14-day trial, so the 5 Oct number is not final.) Who can confirm?
2. Did 100% of traffic get the new page on 3 Oct, with no holdout? (My guess: yes.)
3. Did anything else change between 28 Sep and 8 Oct (promos, emails, pricing, traffic sources)? (My guess: no.)
4. Can someone try the annual checkout today and compare the price to the page?

I've drafted these as questions in `evidence-map.md`. I haven't sent anything. Tell me who should get them, or answer any you already know.

**Next, once you've answered or told me to go ahead:** phase 3 (group and count the tickets, and say whom five tickets don't cover) and phase 4 (the rows by plan, and what the weekly average might hide). For the brief to Dana I'd expect to give a recommendation with a confidence score and what would raise it, given how little post-change data exists.

Files are in `/Users/blurokfarm/Rook industries/06-sidekicks/product-investigation-workspace/iteration-1/eval-clear-ask-documented-user/with_skill/outputs/`: `charter.md`, `working-context.md`, `evidence-map.md`, `reply.md`.
